ARA-290 50mg Australia | Cibinetide Research Peptide
ARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from the erythropoietin (EPO) molecule. It is widely referenced in scientific literature examining inflammation and neural research, and is studied across neuropathic and cellular-protection research models. Unlike EPO, ARA-290 is investigated for its interaction with the innate receptor without stimulating red blood cell production, making it a frequent subject of cellular research.
Supplied as a lyophilised powder in 50mg strength, each batch is independently tested with a Certificate of Analysis (COA) provided for 99%+ purity.
ARA-290 Specifications
Peptide: ARA-290 (Cibinetide)
Strength: 50mg per vial
Form: Lyophilised powder
Purity: 99%+
Verification: COA provided; independently tested
Reconstitution: Sterile water for injection or phosphate buffer — bacteriostatic water is not recommended for ARA-290
Storage: Store at 2–8°C
This product is intended strictly for laboratory research use only. It is not for human or animal consumption, and not for diagnostic or therapeutic use.
